|
1
|
Théry C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–579. 2002.PubMed/NCBI
|
|
2
|
Simons M and Raposo G: Exosomes -
vesicular carriers for inter-cellular communication. Curr Opin Cell
Biol. 21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raposo G, Nijman HW, Stoorvogel W,
Liejendekker R, Harding CV, Melief CJ and Geuze HJ: B lymphocytes
secrete antigen-presenting vesicles. J Exp Med. 183:1161–1172.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zitvogel L, Regnault A, Lozier A, Wolfers
J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G and
Amigorena S: Eradication of established murine tumors using a novel
cell-free vaccine: Dendritic cell-derived exosomes. Nat Med.
4:594–600. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Blanchard N, Lankar D, Faure F, Regnault
A, Dumont C, Raposo G and Hivroz C: TCR activation of human T cells
induces the production of exosomes bearing the TCR/CD3/zeta
complex. J Immunol. 168:3235–3241. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heijnen HF, Schiel AE, Fijnheer R, Geuze
HJ and Sixma JJ: Activated platelets release two types of membrane
vesicles: Microvesicles by surface shedding and exosomes derived
from exocytosis of multivesicular bodies and alpha-granules. Blood.
94:3791–3799. 1999.PubMed/NCBI
|
|
7
|
Fontana S, Saieva L, Taverna S and
Alessandro R: Contribution of proteomics to understanding the role
of tumor-derived exosomes in cancer progression: State of the art
and new perspectives. Proteomics. 13:1581–1594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Jong OG, Van Balkom BW, Schiffelers RM,
Bouten CV and Verhaar MC: Extracellular vesicles: potential roles
in regenerative medicine. Front Immunol. 5:6082014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Torreggiani E, Perut F, Roncuzzi L, Zini
N, Baglìo SR and Baldini N: Exosomes: Novel effectors of human
platelet lysate activity. Eur Cell Mater. 28:137–151.
2014.PubMed/NCBI
|
|
10
|
Yang C and Robbins PD: The roles of
tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol.
2011:8428492011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Filipazzi P, Bürdek M, Villa A, Rivoltini
L and Huber V: Recent advances on the role of tumor exosomes in
immunosuppression and disease progression. Semin Cancer Biol.
22:342–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gong J, Jaiswal R, Mathys JM, Combes V,
Grau GE and Bebawy M: Microparticles and their emerging role in
cancer multidrug resistance. Cancer Treat Rev. 38:226–234. 2012.
View Article : Google Scholar
|
|
13
|
Corcoran C, Rani S, O'Brien K, O'Neill A,
Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, et
al: Docetaxel-resistance in prostate cancer: Evaluating associated
phenotypic changes and potential for resistance transfer via
exosomes. PLoS One. 7:e509992012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Corcoran C, Rani S and O'Driscoll L:
miR-34a is an intracellular and exosomal predictive biomarker for
response to docetaxel with clinical relevance to prostate cancer
progression. Prostate. 74:1320–1334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv MM, Zhu XY, Chen WX, Zhong SL, Hu Q, Ma
TF, Zhang J, Chen L, Tang JH and Zhao JH: Exosomes mediate drug
resistance transfer in MCF-7 breast cancer cells and a probable
mechanism is delivery of P-glycoprotein. Tumour Biol.
35:10773–10779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen WX, Liu XM, Lv MM, Chen L, Zhao JH,
Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, et al: Exosomes from
drug-resistant breast cancer cells transmit chemoresistance by a
horizontal transfer of microRNAs. PLoS One. 9:e952402014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heare T, Hensley MA and Dell'Orfano S:
Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr.
21:365–372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baldini N, Scotlandi K, Barbanti-Bròdano
G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S,
Campanacci M, et al: Expression of P-glycoprotein in high-grade
osteosarcomas in relation to clinical outcome. N Engl J Med.
333:1380–1385. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li S, Sun W, Wang H, Zuo D, Hua Y and Cai
Z: Research progress on the multidrug resistance mechanisms of
osteosarcoma chemotherapy and reversal. Tumour Biol. 36:1329–1338.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roncuzzi L, Pancotti F and Baldini N:
Involvement of HIF-1α activation in the doxorubicin resistance of
human osteosarcoma cells. Oncol Rep. 32:389–394. 2014.PubMed/NCBI
|
|
21
|
Salerno M, Avnet S, Bonuccelli G, Hosogi
S, Granchi D and Baldini N: Impairment of lysosomal activity as a
therapeutic modality targeting cancer stem cells of embryonal
rhabdomyosarcoma cell line RD. PLoS One. 9:e1103402014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
23
|
Su L, Mruk DD, Lui WY, Lee WM and Cheng
CY: P-glycoprotein regulates blood-testis barrier dynamics via its
effects on the occludin/zonula occludens 1 (ZO-1) protein complex
mediated by focal adhesion kinase (FAK). Proc Natl Acad Sci USA.
108:19623–19628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mankin HJ, Hornicek FJ, Rosenberg AE,
Harmon DC and Gebhardt MC: Survival data for 648 patients with
osteosarcoma treated at one institution. Clin Orthop Relat Res.
429:286–291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bacci G, Briccoli A, Rocca M, Ferrari S,
Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, et
al: Neoadjuvant chemotherapy for osteosarcoma of the extremities
with metastases at presentation: Recent experience at the Rizzoli
Institute in 57 patients treated with cisplatin, doxorubicin, and a
high dose of methotrexate and ifosfamide. Ann Oncol. 14:1126–1134.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Borst P and Elferink RO: Mammalian ABC
transporters in health and disease. Annu Rev Biochem. 71:537–592.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE
and Gottesman MM: P-glycoprotein: From genomics to mechanism.
Oncogene. 22:7468–7485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baldini N, Scotlandi K, Serra M, Picci P,
Bacci G, Sottili S and Campanacci M: P-glycoprotein expression in
osteosarcoma: A basis for risk-adapted adjuvant chemotherapy. J
Orthop Res. 17:629–632. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Harguindey S, Orive G, Luis Pedraz J,
Paradiso A and Reshkin SJ: The role of pH dynamics and the
Na+/H+ antiporter in the etiopathogenesis and
treatment of cancer. Two faces of the same coin - one single
nature. Biochim Biophys Acta. 1756:1–24. 2005.PubMed/NCBI
|
|
31
|
Shicang Y, Guijun H, Guisheng Q, Yuying L,
Guoming W and Ruiling G: Efficacy of chemotherapeutic agents under
hypoxic conditions in pulmonary adenocarcinoma multidrug resistant
cell line. J Chemother. 19:203–211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen KG and Sikic BI: Molecular pathways:
Regulation and therapeutic implications of multidrug resistance.
Clin Cancer Res. 18:1863–1869. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Levchenko A, Mehta BM, Niu X, Kang G,
Villafania L, Way D, Polycarpe D, Sadelain M and Larson SM:
Intercellular transfer of P-glycoprotein mediates acquired
multidrug resistance in tumor cells. Proc Natl Acad Sci USA.
102:1933–1938. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao L, Liu W, Xiao J and Cao B: The role
of exosomes and ‘exosomal shuttle microRNA’ in tumorigenesis and
drug resistance. Cancer Lett. 356B:339–346. 2015. View Article : Google Scholar
|
|
35
|
Safaei R, Larson BJ, Cheng TC, Gibson MA,
Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking
and enhanced exosomal export of cisplatin in drug-resistant human
ovarian carcinoma cells. Mol Cancer Ther. 4:1595–1604. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Federici C, Petrucci F, Caimi S, Cesolini
A, Logozzi M, Borghi M, D'Ilio S, Lugini L, Violante N, Azzarito T,
et al: Exosome release and low pH belong to a framework of
resistance of human melanoma cells to cisplatin. PLoS One.
9:e881932014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ramachandran S and Palanisamy V:
Horizontal transfer of RNAs: Exosomes as mediators of intercellular
communication. Wiley Interdiscip Rev RNA. 3:286–293. 2012.
View Article : Google Scholar :
|
